236 related articles for article (PubMed ID: 18443285)
1. Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants.
Sirikantaramas S; Yamazaki M; Saito K
Proc Natl Acad Sci U S A; 2008 May; 105(18):6782-6. PubMed ID: 18443285
[TBL] [Abstract][Full Text] [Related]
2. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.
Yanase K; Sugimoto Y; Tsukahara S; Oh-Hara T; Andoh T; Tsuruo T
Jpn J Cancer Res; 2000 May; 91(5):551-9. PubMed ID: 10835501
[TBL] [Abstract][Full Text] [Related]
5. Characterization of DNA topoisomerase-1 in Spodoptera exigua for toxicity evaluation of camptothecin and hydoxy-camptothecin.
Zhang L; Ma D; Zhang Y; He W; Yang J; Li C; Jiang H
PLoS One; 2013; 8(2):e56458. PubMed ID: 23451051
[TBL] [Abstract][Full Text] [Related]
6. Correlation of camptothecin-producing ability and phylogenetic relationship in the genus Ophiorrhiza.
Viraporn V; Yamazaki M; Saito K; Denduangboripant J; Chayamarit K; Chuanasa T; Sukrong S
Planta Med; 2011 May; 77(7):759-64. PubMed ID: 21104605
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
9. A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance.
Losasso C; Cretaio E; Fiorani P; D'Annessa I; Chillemi G; Benedetti P
Nucleic Acids Res; 2008 Oct; 36(17):5635-44. PubMed ID: 18772225
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.
Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J
Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454
[TBL] [Abstract][Full Text] [Related]
11. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
[TBL] [Abstract][Full Text] [Related]
12. A survival strategy: the coevolution of the camptothecin biosynthetic pathway and self-resistance mechanism.
Sirikantaramas S; Yamazaki M; Saito K
Phytochemistry; 2009; 70(15-16):1894-8. PubMed ID: 19709698
[TBL] [Abstract][Full Text] [Related]
13. New Topoisomerase I mutations are associated with resistance to camptothecin.
Gongora C; Vezzio-Vie N; Tuduri S; Denis V; Causse A; Auzanneau C; Collod-Beroud G; Coquelle A; Pasero P; Pourquier P; Martineau P; Del Rio M
Mol Cancer; 2011 May; 10():64. PubMed ID: 21619602
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin, over four decades of surprising findings.
Lorence A; Nessler CL
Phytochemistry; 2004 Oct; 65(20):2735-49. PubMed ID: 15474560
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.
Tamura H; Kohchi C; Yamada R; Ikeda T; Koiwai O; Patterson E; Keene JD; Okada K; Kjeldsen E; Nishikawa K
Nucleic Acids Res; 1991 Jan; 19(1):69-75. PubMed ID: 1849260
[TBL] [Abstract][Full Text] [Related]
17. Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance.
Yanase K; Sugimoto Y; Andoh T; Tsuruo T
Int J Cancer; 1999 Mar; 81(1):134-40. PubMed ID: 10077164
[TBL] [Abstract][Full Text] [Related]
18. Biotechnology of camptothecin production in Nothapodytes nimmoniana, Ophiorrhiza sp. and Camptotheca acuminata.
Swamy MK; Nath S; Paul S; Jha NK; Purushotham B; Rohit KC; Dey A
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9089-9102. PubMed ID: 34850279
[TBL] [Abstract][Full Text] [Related]
19. Possible clues for camptothecin biosynthesis from the metabolites in camptothecin-producing plants.
Pu X; Zhang CR; Zhu L; Li QL; Huang QM; Zhang L; Luo YG
Fitoterapia; 2019 Apr; 134():113-128. PubMed ID: 30794920
[TBL] [Abstract][Full Text] [Related]
20. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
